Your Navigation:PCAR > Abstract
Search pcar
Pharmaceutical Care and Research: 2017; 17(5):396-398
DOI: 10.5428/pcar20170523
Expression of matrix metalloproteinase 17 in gastric cancer tissue and its clinical significance
1. CHEN Xiang(a
2. LI XingHua(a )
Welcome to PCAR! You are the number 412 reader of this article!
Please cite this article as:
CHEN Xiang,LI XingHua,. Expression of matrix metalloproteinase 17 in gastric cancer tissue and its clinical significance[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2017; 17(5): 396-398.
1. ZUO TingTing,ZHENG RongShou,ZENG HongMei,et al.Epidemiologic status of stomach cancer in China[J].Chin J Clin Oncol,2017,44(1):52-58.In Chinese with English abstract.
2. Sohail A,Marco M,Zhao H,et al.Characterization of the dimerization interface of membrane type 4 (MT4)-matrix metalloproteinase[J].J Biol Chem,2011,286(38):33178-33189.
3. Li Z,Zhang D,Zhang H,et al.Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients[J].Tumour Biol,2014,35(4):3463-3470.
4. Sohail A,Sun Q,Zhao H,et al.MT4-(MMP17) and MT6-MMP (MMP25),a unique set of membrane-anchored matrix metalloproteinases:properties and expressions in cancer[J].Cancer Metastasis Rev,2008,27(2):289-302.
5. Chabottaux V,Sounni N E,Pennington C J,et al.Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases[J].Cancer Res,2006,66(10):5165-5172.
6. Huang C H,Yang W H,Chang S Y,et al.Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis[J].Neoplasia,2009,11(12):1371-1382.
7. Host L,Paye A,Detry B,et al.The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects[J].Int J Cancer,2012,131(7):1537-1548.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330